15 Latest Trends And Trends In ADHD Medication Pregnancy
ADHD Medication During Pregnancy and Breastfeeding
Women suffering from ADHD face a difficult decision about whether to continue or stop taking ADHD medication during pregnancy and breastfeeding. There isn't much information on how long-term exposure to these drugs could affect the foetus.
A recent study published in Molecular Psychiatry shows that children exposed to ADHD medication during utero do not develop neurological developmental disorders like impaired vision or hearing seizures, febrile seizures or IQ impairment. The authors acknowledge that further high-quality studies are required.
Risk/Benefit Analysis
Pregnant women who use ADHD medications must weigh the benefits of taking them against the potential risks to the foetus. The doctors don't have the information to make unambiguous recommendations but they can provide information on the risks and benefits to help pregnant women make an informed decision.
A study published in Molecular Psychiatry found that women who took ADHD medications in early pregnancy did not have a significantly increased risk of fetal cardiac malformations or major birth defects that are structural. Researchers conducted a massive population-based case control study to examine the prevalence of major structural defects in infants who were born to mothers who were taking stimulants during pregnancy. Clinical geneticists and pediatric cardiologists looked over the cases to ensure an accurate case classification and to minimize the possibility of bias.
The study conducted by the researchers had some limitations. In particular, they were not able to differentiate the effects of the medication from those of the disorder that is underlying. This limitation makes it difficult for researchers to determine whether the few associations observed between the groups that were exposed to medication use, or if they were caused by co-morbidities. In addition the study did not look at long-term offspring outcomes.
The study did reveal that babies whose mothers had taken ADHD medications during pregnancy were at slightly higher risk of being admitted to the neonatal intensive care unit (NICU) than those who were born without any medication or had cut back on their medications prior to or during pregnancy. The reason for this was central nervous system-related disorders and the increased risk of admission did not appear to be influenced by which stimulant medication was used during pregnancy.
Women who took stimulant ADHD medication during pregnancy were also at an increased risk of having a caesarean delivery or having a child with an low Apgar score (less than 7). These increases appeared to be independent of the type of medication taken during pregnancy.
The research suggests that the risk of a small amount with the use of ADHD medications during the early stages of pregnancy could be offset by the greater benefit for both mother and child from continued treatment for the woman's disorder. Physicians should discuss this with their patients and, when they are able, assist them in developing strategies for improving their coping skills that can lessen the impact of her disorder on her daily functioning and relationships.
Medication Interactions
Many doctors are faced with the decision of whether to maintain treatment or stop it during pregnancy as more women are diagnosed with ADHD. These decisions are frequently taken without clear and authoritative evidence. Instead, physicians must consider their own expertise in conjunction with the experiences of other doctors and the research on the subject.
The issue of potential risks to infants is difficult to determine. The research that has been conducted on this topic is based on observations rather than controlled studies and a lot of the results are conflicting. Additionally, the majority of studies limit their analysis to live births, which could undervalue the serious teratogenic effects that can cause abortion or termination of the pregnancy. The study that is discussed in the journal club addresses these shortcomings by analyzing both information on deceased and live births.
Conclusion A few studies have found a positive correlation between ADHD medications and certain birth defects, other studies have not shown such a relationship. Most studies show a neutral, or even slightly negative, effect. In the end, a careful risk/benefit analysis must be done in each situation.
It can be difficult, if not impossible for women with ADHD to stop taking their medication. In fact, in a recent article in the Archives of Women's Mental Health, psychologist Jennifer Russell notes that stopping ADHD medication during pregnancy can increase depression, feelings of isolation, and family conflict for these patients. Additionally, the loss of medication can interfere with the ability to complete work-related tasks and safely drive that are crucial aspects of daily life for a lot of people with ADHD.
add in adults medication suggests that women who are not sure whether to continue taking the medication or stop it due to their pregnancy educate family members, coworkers and their friends about the condition, the impact on daily functioning and the advantages of staying on the current treatment plan. It can also help women feel more confident in her decision. Certain medications can be passed through the placenta. If add medication adults decides to not take her ADHD medication while breastfeeding, it is important to be aware that the drug could be transferred to the baby.
Risk of Birth Defects
As the use of ADHD medication to treat the symptoms of attention deficit hyperactivity disorder (ADHD) increases as do concerns about what impact the drugs could have on the fetuses. Recent research published in the journal Molecular Psychiatry has added to the body of knowledge on this issue. Utilizing two huge data sets, researchers were able to look at more than 4.3 million pregnancies and determine whether stimulant medications increased the risk of birth defects. Researchers found that while the risk overall is low, first-trimester ADHD medication exposure was associated with slightly higher risk of specific heart defects like ventriculoseptal defects.
The authors of the study found no connection between the use of early medications and other congenital abnormalities, like facial clefting, or club foot. The results are in line with previous studies showing a small but significant increase in the risk of cardiac malformations among women who started taking ADHD medications before pregnancy. The risk increased in the latter part of pregnancy when a large number of women began to stop taking their medication.
Women who used ADHD medication in the first trimester of their pregnancies were also more likely to undergo a caesarean section, a low Apgar score after delivery and a baby that required help breathing at birth. However the researchers of the study were unable to eliminate bias due to selection by restricting the study to women who didn't have any other medical issues that could have contributed to the findings.
add in adults medication hope that their research will provide doctors with information when they encounter pregnant women. They recommend that, while a discussion of risks and benefits is important, the decision to stop or maintain medication should be based on the woman's needs and the severity of her ADHD symptoms.
The authors warn that, although stopping the medication is a possibility to look into, it is not advised due to the high rate depression and other mental problems for women who are pregnant or have recently given birth. Additionally, research suggests that women who stop taking their medication will have a tough adjustment to life without them after the baby is born.
Nursing
The responsibilities of a new mom can be overwhelming. Women who suffer from ADHD can face severe challenges when they have to manage their symptoms, go to doctor appointments and prepare for the birth of a baby and adjust to new routines. Many women decide to continue taking their ADHD medication during pregnancy.
The risk for breastfeeding infant is minimal because the majority of stimulant medication is absorbed through breast milk in low amounts. However, the amount of exposure to medications by the newborn can vary depending on dosage, frequency it is administered and the time of the day the medication is administered. Additionally, different medications are introduced into the baby's system via the gastrointestinal tract or through breast milk. The impact on a newborn's health is not fully known.
Some physicians may discontinue stimulant medication during a woman’s pregnancy due to the lack of research. This is a difficult choice for the patient, who must weigh the benefits of continuing her medication against the possible risks to the foetus. In the meantime, until more information is available, GPs can inquire about pregnant patients whether they have an history of ADHD or if they intend to take medication in the perinatal phase.
A growing number of studies have revealed that the majority of women are able to safely continue taking their ADHD medication during pregnancy and breastfeeding. In response, an increasing number of patients are opting to continue their medication. They have concluded through consultation with their doctor that the benefits of retaining their current medication outweigh any possible risks.
It is crucial for women suffering from ADHD who are contemplating breastfeeding to seek a specialist psychiatrist's guidance prior to becoming pregnant. They should discuss their medication with their physician and discuss the advantages and disadvantages of continued treatment, including non-pharmacological strategies. Psychoeducation should also be provided to help women with ADHD be aware of their symptoms and underlying disorder, learn about available treatment options and reinforce existing strategies for coping. This should be a multidisciplinary process together with obstetricians, GPs and psychiatry. Pregnancy counseling should consist of a discussion of a treatment plan for the mother and child, and monitoring for indicators of deterioration, and, if necessary adjustments to the medication regime.